Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. INDEFINITE DELIVERY INDEFINITE QUANTITY (IDIQ) CONTRACT FOR SEQUEL-SEQUEL II PRODUCT FAMILY SPECIALIZED SCIENTIFIC EQUIPMENT, REAGENTS AND SERVICES. is a federal award for Usda Ars Pa Aao Acq/Per Prop held by Pacific Biosciences of California, Inc. Estimated value $807K ($100K obligated). Current period of performance ends Jul 31, 2024 (potential Jul 31, 2026). Place of performance: KERRVILLE TX. Related solicitation 12405B21R0001.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. INDEFINITE DELIVERY INDEFINITE QUANTITY (IDIQ) CONTRACT FOR SEQUEL-SEQUEL II PRODUCT FAMILY SPECIALIZED SCIENTIFIC EQUIPMENT, REAGENTS AND SERVICES.
Recompete timing
PublicCurrent PoP ended Jul 31, 2024 (771 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordPacific Biosciences of California, Inc — $7.8M obligated across 81 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 12805B21F0117?
12805B21F0117 (IDIQ pacific biosciences california INC) is a Usda Ars Pa Aao Acq/Per Prop award with a potential value of $807K, currently held by Pacific Biosciences of California, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 12805B-21-F-0117?
12805B-21-F-0117 is the dashed form of PIID 12805B21F0117 (IDIQ pacific biosciences california INC), held by Pacific Biosciences of California, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 12805B21F0117?
Usda Ars Pa Aao Acq/Per Prop awarded 12805B21F0117 to Pacific Biosciences of California, Inc (potential $807K).
Who is the incumbent on 12805B21F0117?
Pacific Biosciences of California, Inc is the incumbent with $7.8M across 81 related awards in SCOUT’s public footprint. The current period of performance ends Jul 31, 2024.
When does Pacific Biosciences of California, Inc’s 12805B21F0117 come up for recompete?
SCOUT tracks a period-of-performance end of Jul 31, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Seen enough? Run one full capture cycle on 12805B21F0117 — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.